Announcement of The Consolidated Financial Report for The 3rd Quarter of 2021

2021.11.4

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2021/11/04 Time of announcement 17:04:13
Subject Announcement of The Consolidated Financial Report for The 3rd Quarter of 2021
Date of events 2021/11/04 To which item it meets paragraph 31
Statement 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2021/11/04
2.Date of the financial reports approved by the audit committee:2021/11/04
3.Start and end dates of financial reports of the reporting period:2021/01/01~2021/09/30
4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):3,067,163
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,927,589
6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):763,881
7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):661,816
8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):483,695
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):488,378
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):1.96
11.Total assets end of the period (thousand NTD):9,734,616
12.Total liabilities end of the period (thousand NTD):4,276,432
13.Equity attributable to owners of parent end of the period (thousand NTD):4,844,127
14.Any other matters that need to be specified:None
TOP